miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma.

MLA

Swarbrick, Alexander, et al. “MiR-380-5p Represses P53 to Control Cellular Survival and Is Associated with Poor Outcome in MYCN-Amplified Neuroblastoma.” Nature Medicine, vol. 16, no. 10, Oct. 2010, pp. 1134–40. EBSCOhost, https://doi.org/10.1038/nm.2227.

APA

Swarbrick, A., Woods, S. L., Shaw, A., Balakrishnan, A., Phua, Y., Nguyen, A., Chanthery, Y., Lim, L., Ashton, L. J., Judson, R. L., Huskey, N., Blelloch, R., Haber, M., Norris, M. D., Lengyel, P., Hackett, C. S., Preiss, T., Chetcuti, A., Sullivan, C. S., & Marcusson, E. G. (2010). miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma. Nature Medicine, 16(10), 1134–1140. https://doi.org/10.1038/nm.2227

Chicago

Swarbrick, Alexander, Susan L. Woods, Alexander Shaw, Asha Balakrishnan, Yuwei Phua, Akira Nguyen, Yvan Chanthery, et al. 2010. “MiR-380-5p Represses P53 to Control Cellular Survival and Is Associated with Poor Outcome in MYCN-Amplified Neuroblastoma.” Nature Medicine 16 (10): 1134–40. doi:10.1038/nm.2227.